상세 보기
Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea (Endocrinol Metab (2022) 37 (929-37) DOI: 10.3803/EnM.2022.1613)
- Kim, H.M.;
- Kang, M.J.;
- Song, S.O.
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0초록
This corrects the article “Metformin and cervical cancer risk in patients with newly diagnosed type 2 diabetes: a population-based study in Korea” in volume 37 on page 929. There was an error in our recently published article in the Acknowledgments section, which should be revised as follows: ACKNOWLEDGMENTS This work was supported by the National Health Insurance Ilsan Hospital grant (NHIMC-2016-20-011). We would like to apologize for any inconvenience or misunderstanding. Copyright © 2023 Korean Endocrine Society.
- 제목
- Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea (Endocrinol Metab (2022) 37 (929-37) DOI: 10.3803/EnM.2022.1613)
- 저자
- Kim, H.M.; Kang, M.J.; Song, S.O.
- 발행일
- 2023-02
- 유형
- Erratum
- 권
- 38
- 호
- 1
- 페이지
- 174 ~ 174